| ASSET | MONTH | % RETURN |
|---|---|---|
Biogen (BIIB) | September 2022 | 37.08% |
Regeneron Pharmaceuticals (REGN) | September 2022 | 19.26% |
Kinross Gold (KGC) | September 2022 | 17.13% |
Penumbra (PEN) | September 2022 | 16.91% |
Ascendis Pharma A-S (ASND) | September 2022 | 15.26% |
YPF Sociedad Anonima (YPF) | September 2022 | 13.53% |
Trip Group Ltd ADR (TCOM) | September 2022 | 9.81% |
Vale SA ADR (VALE) | September 2022 | 9.36% |
Pan American Silver (PAAS) | September 2022 | 8.84% |
Hubbell (HUBB) | September 2022 | 8.8% |
Medpace (MEDP) | September 2022 | 7.98% |
Wheaton Precious Metals (WPM) | September 2022 | 7.83% |
Robinhood Markets (HOOD) | September 2022 | 7.45% |
Eli Lilly and (LLY) | September 2022 | 7.43% |
Palantir Technologies Inc Class A Common Stock (PLTR) | September 2022 | 6.83% |
Aurora Innovation (AUR) | September 2022 | 6.76% |
Netflix (NFLX) | September 2022 | 6.67% |
First Solar (FSLR) | September 2022 | 6.22% |
AngloGold Ashanti (AU) | September 2022 | 5.98% |
Joint Stock Company Kaspikz (KSPI) | September 2022 | 5.98% |
Haleon (HLN) | September 2022 | 5.73% |
Cheniere Energy Partners (CQP) | September 2022 | 5.52% |
Bristol-Myers Squibb (BMY) | September 2022 | 5.49% |
Wynn Resorts (WYNN) | September 2022 | 5.33% |
CyberArk Software (CYBR) | September 2022 | 5.29% |
Large-cap stocks are treated as having a market cap of $10B+.
